Skip to main content

Table 4 Economic consequences of less frequent CD4 monitoring in Italy

From: Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

 

Column A

CD4 2 times/year

Column B

CD4 2.7 times/year

Column C

CD4 3 times/year

Total cost

€ 594.428

€ 799.506

€ 891.642

Cost saving (1st scenario)

€ 297.214

€ 502.292

€ 594.428

Cost saving (2nd scenario)

€ 198.143

€ 403.220

€ 495.357

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us